2012, Number 2
<< Back Next >>
Rev Mex Pediatr 2012; 79 (2)
Chediak-Higashi syndrome, a purpose of a clinical case
Quero HA, Álvarez SRM, Sánchez NLM
Language: Spanish
References: 16
Page: 105-108
PDF size: 102.06 Kb.
ABSTRACT
Chediak-Higashi syndrome (CHS) is a rare autosomal recessive disease, characterized by partial oculocutaneous albinism, frequent pyogenic infections, and the presence of abnormal large granules in leucocytes and other granules containing cells. Strabismus and nystagmus are common. Patient have silver shinning hair, hypopigmented skin in a diffuse form. We present a case of an eleven month girl with a clinical history of chronic upper respiratory infections, with silver shining hair and diffuse hypo and hyperpigmentation, nystagmus, lymphadenopathy and massive hepatomegaly and splenomegaly. Despite the start of immunosuppressive and anti-infections therapy the disease acceleration with bacterial sepsis lead to multiorgan failure and the patient succumbed, secondary to an infections gastroenteritis.
REFERENCES
Introne W, Boissy RE, Gahl WA. Clinical, molecular, and cel biological aspects of Chediak-Higashi syndrome. Mol Genet Metab 1999; 68(2): 283-303.
Ward DM, Griffiths GM, Stinchcombe JC, Kpalan J. Analysis of the lysosomal storage disease Chediak-Higashi syndrome. Traffic 2000; 1: 816-22.
Bejaoui M, Veber F, Girault D, Gaud C, Blanche S, Grsicelli C et al. The accelerated phase of Chediak-Higashi syndrome. Arch Fr Pediatr 1989; 46(10): 733-6.
Rubin CM, Burke BA, McKenna RW, McClain KL, White JG, Nesbit ME Jr et al. The accelerated phase of Chediak-Higashi syndrome. An expression of the virus-associated hemophagocytic syndrome? Cancer 1985; 56(1): 525-30.
Shiflett SL, Kaplan J, Ward DM. Chediak-Higashi syndrome: a rare disorder of lysosomes and lysosome related organelles. Pigment Cell Res 2002; 15(4): 251-7.
Holcombe RF, Straus W, Owen FL, Boxer LA, Warren RW, Conley ME et al. Relationship of the genes for Chediak-Higashi syndrome (beige) and the T-cell receptor gamma chain in mouse and man. Genomics 1987; 1(3): 287-91.
Barbosa MD, Nguyen QA, Tchernev VT, Ashley JA, Detter JC, Blaydes SM et al. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature 1996; 382(6588): 262-5.
Barrat FJ, Auloge L, Pastural E, Lagelouse RD, Vilmer E, Cant AJ et al. Getic and physical mapping of the Chediak-Higashi syndrome on chromosome 1q42-43. Am J Hum Genet 1996; 59(3): 625-32.
Haddad E, Le Deist F, Blanche S, Benkerrou M, Rohrlich P, Vilmer E et al. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases. Blood 1995; 1; 85(11): 3328-33.
Eapen M, DeLaat CA, Baker KS, Cairo MS, Cowan MJ, Kurtzberg J et al. Hematopoietic cell transplantation for Chediak-Higashi syndrome. Bone Marrow Transplant 2007; 39(7): 411-5.
Jones KL, Stewart RM, Fowler M, Fukuda M, Holcombe RF. Chediak-Higashi lymphoblastoid cell lines: granule characteristics and expression of lysosome-associated membrane proteins. Clin Immunol Immunopathol 1992; 65: 219-26.
Dessinioti C, Stratigos AJ, Rigopoulos D, Katsambas D. A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes. Expl Dermatol 2009; 18: 741-9.
Rendu F, Gorius JB, Lebret M, Klebanoff C, Buriot D, Griscelli C et al. Evidence that abnormal platelet functions in human Chediak-Higashi syndrome are the results of a lack of dense bodies. Am J Pathol 1983; 111: 307-14.
Haliotis T, Roder J, Klein M, Ortaldo J, Fauci AS, Herberman RB. Chediak-Higashi gene in humans I: impairment of natural-killer function. J Exp Med 1980; 151: 1039-48.
Targan S, Oseas R. The “lazy” NK cells of Chediak-Higashi syndrome. J Immunol 1983; 130: 2671-4.
Certain S, Barrat F, Pastural E, Le Deist F, Goyo-Rivas J, Jabado N et al. Protein truncation test of LYST reveals heterogeneous mutations in patients with Chediak-Higashi syndrome. Blood 2000; 95(3): 979-83.